FDA food adverse event report
Consumer gender: Female
Consumer age: 57 year(s)
Product(s):
role: SUSPECT
name_brand: REMIFEMIN TABLET (CIMICIFUGA)
industry_name: Vit/Min/Prot/Unconv Diet(Human/Animal)
Reactions:
ANGIONEUROTIC OEDEMA
HEPATIC ENZYME INCREASED
HOSPITALISATION
HYPERSENSITIVITY
LIPIDS INCREASED
OEDEMA PERIPHERAL
PAIN
SWOLLEN TONGUE
URTICARIA
Outcomes:
Life Threatening
Other Serious or Important Medical Event
Visited Emergency Room
Other Serious Outcome